| Title |
Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010
|
|---|---|
| Published in |
CNS Drugs, March 2018
|
| DOI | 10.1007/s40263-018-0488-6 |
| Pubmed ID | |
| Authors |
Simon Faissner, Ralf Gold |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 50% |
| Members of the public | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 126 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 126 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 19 | 15% |
| Student > Master | 14 | 11% |
| Student > Bachelor | 12 | 10% |
| Student > Ph. D. Student | 9 | 7% |
| Student > Doctoral Student | 8 | 6% |
| Other | 22 | 17% |
| Unknown | 42 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 32 | 25% |
| Neuroscience | 16 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 6% |
| Agricultural and Biological Sciences | 6 | 5% |
| Biochemistry, Genetics and Molecular Biology | 4 | 3% |
| Other | 11 | 9% |
| Unknown | 49 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 February 2019.
All research outputs
#15,810,483
of 26,017,215 outputs
Outputs from CNS Drugs
#1,102
of 1,403 outputs
Outputs of similar age
#186,606
of 346,855 outputs
Outputs of similar age from CNS Drugs
#14
of 17 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,403 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 346,855 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.